drugset / Trial / NCT02452905

Finding Better Treatment of Bronchiolitis: A Clinical Trial of Oral Nitazoxanide for the Treatment of Bronchiolitis in Infants Presenting to Hospital Emergency Departments

NCT02452905

Phase 2 Withdrawn Telethon Kids Institute
RandomizedParallel-groupTriple-blindTreatment

Summary

Bronchiolitis is an extremely common cause of respiratory illness in infants caused by viral infection.This study evaluates whether treatment with nitazoxanide (NTZ) reduces the duration and severity of respiratory symptoms caused by bronchiolitis. Half of the participants will receive NTZ while the other half will receive a placebo.

Timeline

Start
2016-12
Primary completion
2017-10
Completion
2018-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Nitazoxanide Other / unclassified 7.5 mg/kg Oral

Indications